Posts Tagged ‘American College of Rheumatology’

  • ACR REF Rheum Research & Courage That Won’t Back Down

    “Hey baby, there ain’t no easy way out… I won’t back down.” We just got back from Miami from the ACR Research Education Foundation (REF) RA Investigators’ Meeting where important research topics were discussed such as Lung disease of RA – our 2nd leading cause of death Rheumatoid heart disease research Porphyromonas gingivalis and the […]

  • ACR’s Research Education Foundation Investigators’ Meeting

    REF RA researchers focus on progress The American College of Rheumatology’s Research Education Foundation has gathered over 50 researchers from across the U.S. to present their data from the Within Our Reach RA studies. They’ll be brainstorming ways to collaborate in finding a cure for RA. The meeting will feature a wide range of RA research […]

  • New Rheumatoid Arthritis Remission Criteria

    One of the most fascinating things at ACR last November was the multi-presentation session on the last day focusing on creating Rheumatoid Arthritis remission criteria. We literally sat on the edge of our seats and took notes about the assorted characterizations of RA remission that have been used concurrently over the last couple of decades, […]

  • American College of Rheumatology Annual Meeting 2010

    What’s the American College of Rheumatology? The American College of Rheumatology (ACR) is an organization of doctors wanting to learn the latest research in rheumatology or who contribute to that research. The better rheumatologists around the world attend the ACR’s annual Scientific Meeting or are members of ACR. (Because of expense and busy practice, many members […]

  • Rheumatoid Arthritis News: Actemra Approved

    New medicine for unresponsive Rheumatoid Arthritis in the news Friday, the U.S. Food and Drug Administration (FDA) approved Actemra (Tocilizumab) to treat severe RA in patients who did not respond to TNF blocking medicines like Enbrel and Humira and other disease modifying drugs DMARDs. Associated Press reports: Hal Barron, chief medical officer for Genentech, a […]

  • 3 Reasons to Stop Saying “Complications of Rheumatoid Arthritis”

    Why “complications of Rheumatoid Arthritis” is an irritating phrase As I read news articles and journal abstracts on Rheumatoid Arthritis almost every day, I am annoyed at the use of the phrase “complications of Rheumatoid Arthritis.” Rheumatoid Arthritis is a complicated autoimmune disease which can attack almost any part or system of the human body. […]

  • American College of Rheumatology Redefines Rheumatoid Arthritis, Part 3

    Will the enthusiasm of Rheumatoid Arthritis patients be short-lived? Reactions have varied to the new diagnosis guidelines which the American College of Rheumatology (ACR) released this week for Rheumatoid Arthritis. Is it good news for RA’ers? People who have Rheumatoid Arthritis often feel such a need for change that any news is good news. But […]

  • American College of Rheumatology Redefines Rheumatoid Arthritis, Part 2

    An early Christmas present from the ACR? The American College of Rheumatology (ACR) announced this week new criteria for diagnosis of Rheumatoid Arthritis. Yesterday, we discussed some of the possible impetus for the change. Today, we’ll look more specifically at the changes. We need to know What is different about the new criteria? Will it […]

  • American College of Rheumatology Redefines Rheumatoid Arthritis

    Change of plans This post was begun last week. The original title of this post was ACR: Change the Diagnosis Guidelines! (It is still that in my laptop.) However, Monday morning I learned that late on Sunday, The American College of Rheumatology in cooperation with the European League Against Rheumatism (EULAR) released new guidelines for […]

  • Hysterical Symptom Diagnosis, Part 2

    True story of a rheumatoid arthritis patient misdiagnosed due to assumptions about a hysterical symptom, with a surprising ending.

Would You Like Free Email Updates?
Stay in touch with RA Warrior.
We respect your privacy. Your email address will never be shared.